Thomas Beetham serves as the Chief Operating Officer (COO) at Viridian Therapeutics, Inc., a biotechnology company focused on developing innovative treatments for serious and rare diseases. In his role as COO, Beetham is responsible for overseeing the company's operational strategies and ensuring the efficient execution of its business plans. His leadership has been instrumental in driving Viridian's growth and advancing its mission to bring life-changing therapies to patients in need. Prior to joining Viridian Therapeutics, Beetham held several high-level positions in the biotechnology and pharmaceutical industries. He has a proven track record of successfully managing complex projects and leading cross-functional teams. Beetham's extensive experience in operations, strategic planning, and business development has been a valuable asset to Viridian, enabling the company to navigate the challenges of drug development and commercialization effectively. Throughout his career, Beetham has demonstrated a strong commitment to innovation and excellence. His strategic vision and operational expertise have contributed significantly to Viridian's progress in developing its pipeline of novel therapies. Under his guidance, the company has made notable advancements in its clinical programs, bringing it closer to its goal of transforming the lives of patients with serious diseases.